It takes just a few minutes and helps our clinical team understand your goals and health needs
Prior GLP-1 experience does not eliminate the need for titration with retatrutide, because the glucagon receptor component introduces a new variable
GLP-1 activates the GLP-1R to stimulate adenylate cyclase (AC), increasing intracellular levels of cyclic AMP (cAMP) (Sandoval and DAlessio, 2015)
The fraction of weight lost as fat-free mass depends on baseline adiposity, age, sex, diet, protein intake, inactivity, resistance training, metabolic state, and the rate and duration of weight loss
Gastrointestinal symptoms that some patients experience while on GLP-1 therapysuch as nausea, reduced appetite, or altered bowel habitsgenerally resolve as the medication clears from the system, typically within 1-2 weeks for short-acting formulations and within 4-8 weeks for long-acting preparations, corresponding to their elimination timelines
What if I do not qualify for full-dose semaglutide